celgene bluebird gene therapy cancer collab

http://www.marketwatch.com/story/bluebird-bio-announces-global-strategic-collaboration-with-celgene-to-advance-gene-therapy-in-oncology-2013-03-21

Notice it also includes Baylor College of Medicine, who are not only licencing Gradalis IP, but also won an NIH grant last year for T Cell gene therapy using shRNA.

http://www.bcm.edu/news/item.cfm?newsID=6286

i didn't see a direct link between shRNA GT and the bluebird programme yet, but it's warm, very warm.